149 related articles for article (PubMed ID: 11130011)
1. Production and radiochemical separation of the Auger electron emitter 140Nd.
Rösch F; Brockmann J; Lebedev NA; Qaim SM
Acta Oncol; 2000; 39(6):727-30. PubMed ID: 11130011
[TBL] [Abstract][Full Text] [Related]
2. An experimental comparison of the K- and L-Auger electron spectra generated in the decays of 140Nd and 111In.
Yakushev EA; Kovalík A; Filosofov DV; Korolev NA; Lebedev NA; Lubashevski AV; Rösch F; Novgorodov AF
Appl Radiat Isot; 2005 Mar; 62(3):451-6. PubMed ID: 15607923
[TBL] [Abstract][Full Text] [Related]
3. New method for production of
Moiseeva AN; Aliev RA; Furkina EB; Novikov VI; Unezhev VN
Nucl Med Biol; 2022; 106-107():52-61. PubMed ID: 35032789
[TBL] [Abstract][Full Text] [Related]
4. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
[TBL] [Abstract][Full Text] [Related]
5. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
[TBL] [Abstract][Full Text] [Related]
6. Radiochemical determination of cross sections of alpha-particle induced reactions on 192Os for the production of the therapeutic radionuclide 193mPt.
Uddin MS; Scholten B; Hermanne A; Sudár S; Coenen HH; Qaim SM
Appl Radiat Isot; 2010 Oct; 68(10):2001-6. PubMed ID: 20538474
[TBL] [Abstract][Full Text] [Related]
7. High Separation Factor, High Molar Activity, and Inexpensive Purification Method for the Production of Pure
Saghez BS; Yang H; Radchenko V
Inorg Chem; 2024 Mar; 63(12):5330-5340. PubMed ID: 38324916
[No Abstract] [Full Text] [Related]
8. Production and dosimetric aspects of the potent Auger emitter 58mCo for targeted radionuclide therapy of small tumors.
Thisgaard H; Elema DR; Jensen M
Med Phys; 2011 Aug; 38(8):4535-41. PubMed ID: 21928624
[TBL] [Abstract][Full Text] [Related]
9. Improved procedures for production and purification of
Pedersen KS; Deville C; Søndergaard U; Jensen M; Jensen AI
Appl Radiat Isot; 2023 Feb; 192():110612. PubMed ID: 36521259
[TBL] [Abstract][Full Text] [Related]
10. Production and separation of no-carrier-added radioactive tracers of yttrium, strontium and rubidium from heavy-ion irradiated germanium target: applicability to the standardization of a separation technique for production of positron-emitting radionuclide 86Y.
Pal S; Chattopadhyay S; Das MK; Sudersanan M
Appl Radiat Isot; 2006 Dec; 64(12):1521-7. PubMed ID: 16822676
[TBL] [Abstract][Full Text] [Related]
11. Preparation of radioactive praseodymium oxide as a multifunctional agent in nuclear medicine: expanding the horizons of cancer therapy using nanosized neodymium oxide.
Bakht MK; Sadeghi M; Ahmadi SJ; Sadjadi SS; Tenreiro C
Nucl Med Commun; 2013 Jan; 34(1):5-12. PubMed ID: 23104000
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Radiometals Beyond
Müller C; van der Meulen NP; Benešová M; Schibli R
J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619
[TBL] [Abstract][Full Text] [Related]
13. The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy.
Lehenberger S; Barkhausen C; Cohrs S; Fischer E; Grünberg J; Hohn A; Köster U; Schibli R; Türler A; Zhernosekov K
Nucl Med Biol; 2011 Aug; 38(6):917-24. PubMed ID: 21843788
[TBL] [Abstract][Full Text] [Related]
14. A compilation of microdosimetry for uniformly distributed Auger emitters used in medicine.
Chen J
Int J Radiat Biol; 2008 Dec; 84(12):1027-33. PubMed ID: 19061126
[TBL] [Abstract][Full Text] [Related]
15. Excitation functions of natGe(p,xn)71,72,73,74 As reactions up to 100 MeV with a focus on the production of 72 As for medical and 73 As for environmental studies.
Spahn I; Steyn GF; Nortier FM; Coenen HH; Qaim SM
Appl Radiat Isot; 2007 Sep; 65(9):1057-64. PubMed ID: 17574855
[TBL] [Abstract][Full Text] [Related]
16.
Fonslet J; Lee BQ; Tran TA; Siragusa M; Jensen M; Kibédi T; Stuchbery AE; Severin GW
Phys Med Biol; 2017 Dec; 63(1):015026. PubMed ID: 29286003
[No Abstract] [Full Text] [Related]
17. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
[TBL] [Abstract][Full Text] [Related]
18. Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with
Kostelnik TI; Olson AP; Grundmane A; Ellison PA; Mynerich J; Chen S; Marinova A; Randhawa P; Karaivanov D; Aluicio-Sarduy E; Barnhart TE; Orvig C; Ramogida CF; Hoehr C; Filosofov D; Engle JW; Radchenko V
Nucl Med Biol; 2023; 122-123():108352. PubMed ID: 37390607
[TBL] [Abstract][Full Text] [Related]
19. Excitation functions of 85Rb(p,xn)(85m,g,83,82,81)Sr reactions up to 100 MeV: integral tests of cross section data, comparison of production routes of 83Sr and thick target yield of 82Sr.
Kastleiner S; Qaim SM; Nortier FM; Blessing G; van der Walt TN; Coenen HH
Appl Radiat Isot; 2002 May; 56(5):685-95. PubMed ID: 11993943
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
